Respiratory problems

Author(s):  
Grenville Fox ◽  
Nicholas Hoque ◽  
Timothy Watts

This chapter outlines the causes and initial management of respiratory distress in the newborn and gives a comprehensive description and guidelines for the management of common neonatal respiratory conditions such as surfactant deficiency lung disease, chronic lung disease of prematurity, and meconium aspiration syndrome. Congenital malformations of the respiratory system are detailed, including diaphragmatic hernia, and upper airway problems and obstruction. A separate chapter on neonatal respiratory support (Chapter 8) gives further detail on ventilation and non-invasive respiratory support.

2017 ◽  
Vol 11 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Wilfredo De Jesus Rojas ◽  
Cheryl L. Samuels ◽  
Traci R. Gonzales ◽  
Katrina E. McBeth ◽  
Aravind Yadav ◽  
...  

Background: Nasal non-invasive-ventilation (Nasal NIV) is a mode of ventilatory support providing positive pressure to patients via a nasal interface. The RAM Cannula is an oxygen delivery device that can be used as an alternative approach to deliver positive pressure. Together they have been successfully used to provide respiratory support in neonatal in-patient settings. Objective: To describe the outpatient use of Nasal NIV/RAM Cannula as a feasible alternative for home respiratory support in children with chronic respiratory failure. Methods: We performed a retrospective case series of 18 children (4 months to 19 years old) using the Nasal NIV/RAM Cannula in the Pediatric Pulmonary Clinic at the McGovern Medical School, UTHealth (2014-16). Consideration for Nasal NIV/RAM Cannula utilization included: inability to wean-off in-patient respiratory support, comfort for dyspnea, intolerability of conventional mask interfaces and tracheostomy avoidance. Results: Average age was 7 years. 50% were Caucasian, 38% African-American and 11% Hispanics. Pulmonary disorders included: chest wall weakness (38%), central control abnormalities (33%), obstructive lung disease (16%) and restrictive lung disease (11%). Indications for Nasal NIV/RAM Cannula initiation included: CPAP/BPAP masks intolerability (11%), dyspnea secondary to chest wall weakness (38%) and tracheostomy avoidance (50%). Average length of use of Nasal NIV/RAM Cannula was 8.4 months. Successful implementation of Nasal NIV/Ram Cannula was 94%. One patient required a tracheostomy following the use of Nasal NIV/RAM Cannula. Significant decrease in arterial PaCO2 pre and post Nasal NIV/RAM cannula initiation was notable (p=0.001). Conclusion: Outpatient use of Nasal NIV/RAM Cannula may prove to be a feasible and save treatment alternative for children with chronic respiratory failure, chest wall weakness, dyspnea and traditional nasal/face mask intolerance to avoid tracheostomy.


Author(s):  
Grenville Fox ◽  
Nicholas Hoque ◽  
Timothy Watts

This chapter includes sections on various modes of both invasive (i.e. via an endotracheal tube) and non-invasive respiratory support in neonates, including conventional ventilation, volume-targeted ventilation, high-frequency oscillatory ventilation (HFOV), extracorporeal membrane oxygenation (ECMO), nasal continuous positive airways pressure (nCPAP), nasal intermittent positive pressure ventilation (nIPPV), and high and low-flow nasal cannula oxygen. There is also a brief section on the care of babies with a tracheostomy as well as management of babies requiring home oxygen. Reference is made to the most recent European Consensus Guidelines. A separate chapter on neonatal respiratory problems (Chapter 7) gives further detail on common lung pathologies requiring respiratory support in neonates.


Author(s):  
Vinod Idicula Oommen ◽  
Viraraghavan Vadakkencherry Ramaswamy ◽  
Edgardo Szyld ◽  
Charles Christoph Roehr

BackgroundWe investigated the impact of policy change in delivery room resuscitation from routine endotracheal (ET) suctioning of non-vigorous neonates born through meconium-stained amniotic fluid (MSAF) to immediate non-invasive respiratory support.DesignSingle-centre cohort study. Prospective group (October 2016–September 2017)—non-vigorous neonates born through MSAF managed according to the current (2015) guidance of commencing respiratory support without prior suctioning. Retrospective group (August 2015–July 2016)—non-vigorous neonates born through MSAF who underwent routine ET suctioning.Results1138 neonates born through MSAF were analysed. No differences in the incidence of meconium aspiration syndrome (MAS), requirement of mechanical ventilation, inhaled nitric oxide or surfactant therapy were found between groups. Less neonatal intensive care unit (NICU) admissions were necessary in the prospective cohort compared with the retrospective group (19.1% vs 55.6%, respectively; p<0.05).ConclusionThe policy change towards not routinely suctioning non-vigorous neonates born through MSAF at birth was not associated with an increase in the local incidence of MAS and was associated with fewer NICU admissions.


2017 ◽  
Vol 03 (01) ◽  
pp. 21
Author(s):  
Refika Ersu ◽  

Sleep is a vulnerable period for the respiratory system. Patients with chronic lung disease (CLD) may be at risk for hypoxemia during sleep; they have reduced baseline arterial oxygen pressure that develops with advancing lung disease. Nocturnal hypercapnia may be present in CLD without nocturnal hypoxemia or daytime gas-exchange abnormalities. Increased upper airway resistance, including nasal obstruction, is a risk factor for obstructive sleep apnoea in children with cystic fibrosis and primary ciliary dyskinesia. Sleep problems are usually underestimated in these patients. Non-invasive ventilation and supplemental oxygen may be helpful in mitigating the adverse effects of nocturnal hypercapnia and hypoxemia. Sleep should be evaluated in children with CLD to improve the care of these patients.


Author(s):  
Dejan Radovanovic ◽  
Silvia Coppola ◽  
Elisa Franceschi ◽  
Fabrizio Gervasoni ◽  
Eleonora Duscio ◽  
...  

2021 ◽  
Vol 38 (4) ◽  
pp. 1746-1756
Author(s):  
Sharon Einav ◽  
Ines Lakbar ◽  
Marc Leone

Sign in / Sign up

Export Citation Format

Share Document